510(k) · Cleared
ClearedNautilus VF ECMO Oxygenator
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Mc3, Inc. · BYS Oxygenator, Long Term Support Greater Than 6 Hours
Cleared on Oct 4, 2023 as substantially equivalent to K191935 (Mc3 Incorporated, 2020) after a 23-day review. Its family tree reaches back 1 generation to 2020.
- Decided
- Oct 4, 2023
- Review
- 23 days
- Class
- Class II
- Product code
- BYS
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K191935 (2020). No later device cites it as a predicate yet.
- Root · 1 generation backK191935 Nautilus Smart ECMO ModuleMc3 Incorporated · 2020 · Recalled
- This deviceK232767 Nautilus VF ECMO OxygenatorMc3, Inc. · 2023
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K191935 | Nautilus Smart ECMO Module | Mc3 Incorporated | 2020 | 2 |
| 0 (this device) | K232767 | Nautilus VF ECMO Oxygenator | Mc3, Inc. | 2023 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in BYS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K191935 | Nautilus Smart ECMO ModuleSummary page 4…21 CFR 870.4100 Product Code: BYS Predicate: Nautilus™ Smart ECMO Module (K191935) Nautilus™ ECMO Oxygenator (K191935) Indications for Use: The NautilusTM VF ECM… | 2020 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has a recall.
How does its category compare?
All BYS devicesBYS Oxygenator, Long Term Support Greater Than 6 Hours: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · BYS
1in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · BYS
Too few BYS 510(k)s in any year since 2007 to give a median.
Recalls per year · BYS
No recall names BYS since 2007.
Adverse event reports per year · BYS
60in 2025
MAUDE reports naming product code BYS, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 9 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 1 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 5 |
| 2022 | 0 | — | 0 | 2 |
| 2023 | 1 | — | 0 | 20 |
| 2024 | 0 | — | 0 | 42 |
| 2025 | 0 | — | 0 | 60 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Nautilus VF ECMO Oxygenator with integrated heat exchanger is intended to provide assisted
long-term extracorporeal circulation and physiologic gas exchange (oxygenation and carbon dioxide
removal) of the patient's blood for up to 48 hours in adult and pediatric adolescent patients with
acute respiratory failure or acute cardiopulmonary failure, where other available treatment options
have failed, and continued clinical deterioration is expected or the risk of death is imminent. The
integrated heat exchanger is intended to heat or cool the blood as needed during use. Integrated
fluid path pressure, temperature, and oxygen saturation monitoring is achieved by built-in sensor
modules.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K232767 · printed Nov 5, 2026
Cite this page
510(k) Report. “K232767: Nautilus VF ECMO Oxygenator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K232767
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026